annual EBITDA:
-$274.66M+$66.68M(+19.54%)Summary
- As of today (July 26, 2025), SWTX annual EBITDA is -$274.66 million, with the most recent change of +$66.68 million (+19.54%) on December 31, 2024.
- During the last 3 years, SWTX annual EBITDA has fallen by -$101.69 million (-58.78%).
Performance
SWTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
quarterly EBITDA:
-$81.09M-$763.00K(-0.95%)Summary
- As of today (July 26, 2025), SWTX quarterly EBITDA is -$81.09 million, with the most recent change of -$763.00 thousand (-0.95%) on March 31, 2025.
- Over the past year, SWTX quarterly EBITDA has increased by +$12.11 million (+13.00%).
Performance
SWTX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
TTM EBITDA:
-$262.55M+$12.11M(+4.41%)Summary
- As of today (July 26, 2025), SWTX TTM EBITDA is -$262.55 million, with the most recent change of +$12.11 million (+4.41%) on March 31, 2025.
- Over the past year, SWTX TTM EBITDA has increased by +$94.55 million (+26.48%).
Performance
SWTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SWTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +19.5% | +13.0% | +26.5% |
| 3 y3 years | -58.8% | -32.1% | -28.3% |
| 5 y5 years | -365.2% | -404.9% | -284.0% |
SWTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +58.8% | -19.5% | +84.0% | -17.2% | +15.9% | -26.5% |
| 5 y | 5-year | +497.4% | -19.5% | -815.8% | -17.2% | +471.1% | -26.5% |
| alltime | all time | +1386.8% | -19.5% | -815.8% | -17.2% | +4922.9% | -26.5% |
SWTX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$81.09M(+0.9%) | -$262.55M(-4.4%) |
| Dec 2024 | -$274.66M(-19.5%) | -$80.33M(+40.8%) | -$274.66M(-6.0%) |
| Sep 2024 | - | -$57.06M(+29.5%) | -$292.26M(-8.3%) |
| Jun 2024 | - | -$44.08M(-52.7%) | -$318.71M(-10.8%) |
| Mar 2024 | - | -$93.20M(-4.8%) | -$357.10M(+4.6%) |
| Dec 2023 | -$341.35M(+21.9%) | -$97.92M(+17.3%) | -$341.35M(+6.1%) |
| Sep 2023 | - | -$83.50M(+1.3%) | -$321.62M(+3.9%) |
| Jun 2023 | - | -$82.47M(+6.5%) | -$309.64M(+4.6%) |
| Mar 2023 | - | -$77.45M(-1.0%) | -$295.99M(+5.7%) |
| Dec 2022 | -$279.91M(+61.8%) | -$78.20M(+9.3%) | -$279.91M(+8.8%) |
| Sep 2022 | - | -$71.53M(+3.9%) | -$257.36M(+13.6%) |
| Jun 2022 | - | -$68.82M(+12.2%) | -$226.61M(+10.7%) |
| Mar 2022 | - | -$61.36M(+10.3%) | -$204.69M(+18.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$172.98M(+276.2%) | -$55.65M(+36.5%) | -$172.98M(+63.2%) |
| Sep 2021 | - | -$40.78M(-13.1%) | -$106.00M(+22.2%) |
| Jun 2021 | - | -$46.91M(+58.2%) | -$86.72M(+45.6%) |
| Mar 2021 | - | -$29.65M(-361.7%) | -$59.56M(+29.6%) |
| Dec 2020 | -$45.98M(-22.1%) | $11.33M(-152.7%) | -$45.98M(-38.4%) |
| Sep 2020 | - | -$21.50M(+8.9%) | -$74.61M(+9.1%) |
| Jun 2020 | - | -$19.75M(+23.0%) | -$68.38M(+7.8%) |
| Mar 2020 | - | -$16.06M(-7.2%) | -$63.44M(+7.4%) |
| Dec 2019 | -$59.05M(+219.6%) | -$17.31M(+13.4%) | -$59.05M(+22.6%) |
| Sep 2019 | - | -$15.27M(+3.1%) | -$48.18M(+26.3%) |
| Jun 2019 | - | -$14.81M(+26.9%) | -$38.14M(+63.5%) |
| Mar 2019 | - | -$11.67M(+81.2%) | -$23.33M(+100.0%) |
| Dec 2018 | -$18.47M | -$6.44M(+23.2%) | -$11.67M(+123.2%) |
| Sep 2018 | - | -$5.23M | -$5.23M |
FAQ
- What is SpringWorks Therapeutics, Inc. annual EBITDA?
- What is the all time high annual EBITDA for SpringWorks Therapeutics, Inc.?
- What is SpringWorks Therapeutics, Inc. annual EBITDA year-on-year change?
- What is SpringWorks Therapeutics, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for SpringWorks Therapeutics, Inc.?
- What is SpringWorks Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is SpringWorks Therapeutics, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for SpringWorks Therapeutics, Inc.?
- What is SpringWorks Therapeutics, Inc. TTM EBITDA year-on-year change?
What is SpringWorks Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of SWTX is -$274.66M
What is the all time high annual EBITDA for SpringWorks Therapeutics, Inc.?
SpringWorks Therapeutics, Inc. all-time high annual EBITDA is -$18.47M
What is SpringWorks Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, SWTX annual EBITDA has changed by +$66.68M (+19.54%)
What is SpringWorks Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of SWTX is -$81.09M
What is the all time high quarterly EBITDA for SpringWorks Therapeutics, Inc.?
SpringWorks Therapeutics, Inc. all-time high quarterly EBITDA is $11.33M
What is SpringWorks Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, SWTX quarterly EBITDA has changed by +$12.11M (+13.00%)
What is SpringWorks Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of SWTX is -$262.55M
What is the all time high TTM EBITDA for SpringWorks Therapeutics, Inc.?
SpringWorks Therapeutics, Inc. all-time high TTM EBITDA is -$5.23M
What is SpringWorks Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, SWTX TTM EBITDA has changed by +$94.55M (+26.48%)